Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZM0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,973
Award facts
- Contract value 100% obligated
- $6,973.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector units. The contract is a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and was awarded on January 8, 2026, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company operates as a subsidiary of Cencora, Inc., which maintains a comprehensive indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
This delivery order is executed under the broader pharmaceutical prime vendor contract vehicle established between DLA Troop Support Medical and Cencora, Inc., which enables the supply of a vast range of pharmaceutical products and medical supplies to support military healthcare programs globally. Benlysta (belimumab) is a biologic immunosuppressant medication used primarily to treat systemic lupus erythematosus, reflecting the specialized nature of pharmaceutical commodities available through this contract mechanism. The award demonstrates AmerisourceBergen's capability to fulfill competitive federal procurement requirements for critical specialty medications required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F0ZM0?
SPE2DR26F0ZM0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F0ZM0 worth?
The government has obligated $6,973 on SPE2DR26F0ZM0.
Is contract SPE2DR26F0ZM0 an order under another contract?
Yes. SPE2DR26F0ZM0 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZM0 competed?
The extent of competition for SPE2DR26F0ZM0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award